Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
Abstract Nonalcoholic steatohepatitis (NASH) is considered as a progressive form of nonalcoholic fatty liver disease (NAFLD). To distinguish NASH from nonalcoholic fatty liver (NAFL), we evaluated the diagnostic value of circulating miRNAs. Small RNA sequencing was performed on 12 NAFL patients and...
Guardado en:
Autores principales: | Tae Hyung Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim, Eunjung Ko, Sun Young Yim, Young Kul Jung, SeongHee Kang, Moon Young Kim, Hayeon Kim, Baek-hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57af42f491184a57a296eb4ffbc08ce0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.
por: Jeong-An Gim, et al.
Publicado: (2021) -
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
por: Kook Hwan Kim, et al.
Publicado: (2018) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021) -
Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
por: Young-Sun Lee, et al.
Publicado: (2017) -
Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
por: Xuerong Wen, et al.
Publicado: (2021)